ADINA CATALOGUE
Shop the
complete catalogue.
Search by product name or browse by category. Price, availability and the most important distinction stay visible throughout.
Showing 25–43 of 43 results
-
Early human evidence

LL-37
£59.005 mgBatch file pendingDirect antimicrobial membrane activity separates it from immune regulators such as KPV or thymosin alpha-1.
UnavailableAsk about availability -
Established

Oxytocin
£42.0010 mgBatch file pendingA licensed endogenous hormone with direct smooth-muscle effects, not a kisspeptin/GnRH-axis activator.
UnavailableAsk about availability -
Experimental

P21
£58.0010 mgBatch file pendingA CNTF-lineage neurotrophic research material whose exact sequence must be verified before meaningful comparison.
UnavailableAsk about availability -
Early human evidence

Pal-GHK
£38.0010 mgBatch file pendingPalmitoylation—not copper binding—is the defining modification.
UnavailableAsk about availability -
Experimental

PEG-MGF
£61.002 mgBatch file pendingA modified splice-variant fragment rather than a direct full IGF-1 receptor analogue.
UnavailableAsk about availability -
Experimental

Pinealon
£46.0020 mgBatch file pendingA tissue-bioregulator concept with uncertain targets, unlike receptor-defined Semax or Selank research.
UnavailableAsk about availability -
Established

PT-141 (Bremelanotide)
£24.9910 mgBatch file pendingA centrally acting melanocortin agonist, mechanistically separate from reproductive-axis peptides such as kisspeptin.
Available · 20 in stockAdd to basket -
Early human evidence

Selank
Price range: £34.99 through £52.9910 mgBatch file pendingTuftsin-derived and primarily anxiolytic/neuroimmune in focus, unlike the ACTH-derived Semax.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Early human evidence

Semax
Price range: £24.99 through £42.9910 mgBatch file pendingACTH-fragment lineage and neuroprotection focus distinguish it from Selank’s tuftsin/anxiety profile.
Available · 20 in stockAdd to basket This product has multiple variants. The options may be chosen on the product page -
Established

Sermorelin
£49.005 mgBatch file pendingClosest to the natural active GHRH sequence and shorter acting than tesamorelin or CJC-1295 DAC.
UnavailableAsk about availability -
Early human evidence

SNAP-8
£35.0010 mgBatch file pendingA topical neurotransmitter-release-mimetic cosmetic peptide rather than a matrix-remodelling peptide.
UnavailableAsk about availability -
Clinical research

SS-31 (Elamipretide)
£29.9910 mgBatch file pendingDirectly targets mitochondrial membrane cardiolipin, unlike MOTS-c’s signalling-peptide role.
UnavailableAsk about availability -
Established

Thymosin Alpha-1
£69.0010 mgBatch file pendingAn immune-response modulator with human clinical literature, distinct from LL-37’s direct antimicrobial activity.
UnavailableAsk about availability -
Early human evidence

Thymosin Beta-4
£62.0010 mgBatch file pendingFull-length endogenous thymosin beta-4 with broader actin biology, rather than the shorter TB-500-style material.
UnavailableAsk about availability -
Experimental

Vesugen
£46.0020 mgBatch file pendingVascular-tissue focus distinguishes it from mitochondrial or general healthy-ageing peptides.
UnavailableAsk about availability -
Experimental

Vilon
£46.0020 mgBatch file pendingA minimal dipeptide bioregulator, much smaller and less mechanistically defined than thymosin alpha-1.
UnavailableAsk about availability -
Clinical research

VIP
Price range: £29.99 through £38.995 mgBatch file pendingA receptor-defined pleiotropic neuropeptide with direct vasodilatory and bronchodilatory effects.
UnavailableAsk about availability This product has multiple variants. The options may be chosen on the product page

